Skip to Main Content Area
  • English
  • Français
  • accueil
  • Contact
Home
  • Who are we ?
    • Associative project
    • Status
    • History
      • History
      • AirHelp
        • Respiratory physiotherapy
  • Meveol
    • New therapeutic way
    • Scientific data
    • Publications
    • Publications Meveol
    • Meveol Resultats
    • Mechanisms Mévéol
  • The cystic fibrosis
    • A genetic disease
    • Mechanisms and symptoms
    • Key figures
    • Meveol Project
Home »

Actualités

11/17/2011 Donner sa chance à l'innovation
11/29/2010 New Site, help us improve.
06/22/2010 Meveol vs Mycobacterium abscessus
06/22/2010 Mycobacterium abscessus vs. Meveol
06/22/2010 Meveol vs Mycobacterium abscessus
06/20/2010 Meveol vs Mycobacterium abscessus
04/09/2010 Cystic supports the program Meveol
04/09/2010 Mucovie soutient le programme Meveol
12/09/2009 Meveol : orphan drug status granted by the FDA for the treatment of cystic fibrosis.
12/09/2009 Meveol: statut de médicament orphelin accordé par la FDA pour le traitement de la fibrose kystique.
10/17/2009 Jean Paul Perraudin Meveol present at Beijing, 9th World Congress Lactoferrin
10/17/2009 Jean Paul Perraudin presents Meveol at Beijing, 9th Lactoferrin World Congress
09/03/2009 Meveol is designated orphan medicinal product in Europe for the treatment of cystic fibrosis.
09/03/2009 Designated orphan medicinal Meveol IS product in Europe for the Treatment of cystic fibrosis.
Happy New Year 2010
Howard Hinton Sevens
Event planner first news
Bonne année 2010
Howard Hinton Sevens
Meveol vs Mycobacterium abscessus

         

Copyright © 2010 Mucoviscidose-Innovation Une association engagée dans la lutte contre la mucoviscidose
Siège de l'association : 59, Bd de Strasbourg 75010 PARIS - Tel : 01 83 64 12 24
Mentions légales - Réalisé par Solugiciel.com

Feedback

If you experience a bug or would like to see an addition on the current page, feel free to leave us a message.